Skip to main content
Sopharma Properties REIT logo

Sopharma Properties REIT — Investor Relations & Filings

Ticker · SFI ISIN · BG1100031068 LEI · 8945008OK90PXHE1RL82 BSOBGN Real estate activities
Open in API
Filings indexed 69 across all filing types
Latest filing 2024-01-29 Audit Report / Informat…
Country BG Bulgaria
Listing BSOBGN SFI

About Sopharma Properties REIT

https://sopharma-imoti.com/english-home/

Sopharma Properties REIT is a special purpose investment company that focuses on the securitization of real estate. The company's primary activity involves investing in the real estate sector by acquiring, developing, and constructing properties. These assets are primarily managed for rental and leasing purposes. The company also engages in the selling of properties and provides real estate management services on a fee basis. Its investment strategy includes purchasing titles and other rights over land and various real estate assets.

Recent filings

Filing Released Lang Actions
102_Notes to the FS_SFI_Q4_2023.docx
Audit Report / Information Classification · 98% confidence The document text is structured as a comprehensive financial report, containing a Table of Contents (СЪДЪРЖАНИЕ) listing key financial statements such as 'ОТЧЕТ ЗА ВСЕОБХВАТНИЯ ДОХОД' (Statement of Comprehensive Income), 'ОТЧЕТ ЗА ФИНАНСОВОТО СЪСТОЯНИЕ' (Statement of Financial Position), 'ОТЧЕТ ЗА ПАРИЧНИТЕ ПОТОЦИ' (Cash Flow Statement), and detailed notes (ПРИЛОЖЕНИЯ КЪМ ФИНАНСОВИЯ ОТЧЕТ). It also includes sections on the company's business, macroeconomic environment, and detailed accounting policies ('ОСНОВНИ ПОЛОЖЕНИЯ ОТ СЧЕТОВОДНАТА ПОЛИТИКА'). The content is extensive (over 150,000 characters) and covers a full reporting period (references to 31.12.2023 and 31.12.2022 data, and discussion of 2020-2022 macroeconomic indicators). This level of detail and structure strongly indicates a comprehensive annual or interim financial report, rather than a brief release (ER) or a mere announcement of a report (RPA/RNS). Since it covers the full year's performance (implied by the detailed year-end balance sheet data and multi-year comparisons), it aligns best with the definition of an Annual Report (10-K equivalent for non-US filers, or a comprehensive annual filing). Given the options, '10-K' is the closest analogue for a full annual financial report, although 'IR' (Interim/Quarterly Report) is also possible if the document is for a half-year period. However, the depth and the inclusion of multi-year historical data strongly suggest an annual filing context, making 10-K the most appropriate classification for a comprehensive yearly financial statement package. FY 2023
2024-01-29 Bulgarian
SFI Q4_2023_doklad_za_Deinostta.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'МЕЖДИНЕН ДОКЛАД' (Interim Report) for the period ending 31.12.2023. It contains detailed financial statements, analysis of business activities, revenue and expense breakdowns, and management commentary for the company 'Софарма имоти' АДСИЦ. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. FY 2023
2024-01-29 Bulgarian
SFI Q4_2023_info_pril. №4 Nar 2.pdf
AGM Information Classification · 99% confidence The document is titled "Приложение № 4 към чл. 12, ал. 1, т. 1 от Наредба № 2 от 09.11.2021 г. на КФН на "Софарма имоти" АДСИЦ за периода от 01.01.2023 г. до 31.12.2023 г." (Appendix No. 4 to Art. 12, para. 1, item 1 of Regulation No. 2 of 09.11.2021 of the FSC of "Sopharma Properties" REIT for the period from 01.01.2023 to 31.12.2023). This structure strongly suggests a mandatory regulatory disclosure related to the annual financial reporting cycle, specifically covering shareholder structure changes, auditor changes, dividend decisions based on the 2022 results, and significant events occurring during 2023, culminating in a reference to the audited financial report for 2023 being disclosed. While it discusses the Annual General Meeting (AGM) decisions (like auditor change and dividend approval), the content is a summary of required disclosures for the full fiscal year (ending 31.12.2023) mandated by the Bulgarian Financial Supervision Commission (КФН). This type of comprehensive annual disclosure, which is not the full 10-K equivalent but a specific regulatory appendix summarizing key annual events and shareholder information, most closely aligns with the scope of an Annual Report (10-K) or a detailed Interim/Quarterly Report (IR) if it were for a shorter period. Given the reference to the full year 2023 and the nature of the disclosures (shareholder structure, auditor appointment for 2023 audit, dividend based on 2022 results), it functions as a key component of the annual reporting package. However, since it is a specific appendix/disclosure rather than the main 10-K document itself, and it summarizes annual events, it is best classified as a comprehensive annual disclosure. In the provided list, the closest fit for a comprehensive annual summary disclosure that isn't the full 10-K is often the Annual Report (10-K) if it covers the full year, or potentially a Regulatory Filing (RNS) if it were just an announcement. Since this document contains detailed financial/structural information for the entire year, it is more substantial than a simple RPA or RNS. Given the context of Bulgarian REIT reporting, this appendix often accompanies the main annual filing. Since the document explicitly covers the period ending 31.12.2023 and discusses the auditor appointed for the 2023 audit, it is a core part of the annual reporting cycle. If a specific 'Annual Disclosure' code existed, it would fit there. Lacking that, and given its comprehensive nature covering the entire fiscal year's significant events, it is classified as 10-K, as it serves the function of the annual report summary required by local regulation, even if it's an appendix to a larger filing structure.
2024-01-29 Bulgarian
SFI_Q4_prepratka za v. info_chl 7 Regl_596.pdf
Earnings Release Classification · 99% confidence The document is a compilation of 'Вътрешна информация' (Inside Information) disclosures made by "Софарма имоти" АДСИЦ throughout 2023 and early 2024, referencing Bulgarian Financial Supervision Commission (KFN) regulations and EU Market Abuse Regulation (MAR) articles (like Art. 19 and Art. 17). The content includes several types of announcements: Director's Dealings/Insider Transactions (Art. 19 notifications regarding share purchases/donations by related parties like "Софарма" АД and executives), Dividend announcements (June 13), Capital/Financing updates (early loan repayments in May and January), and announcements of Financial Reports (Quarterly/Annual reports). Since the document itself is a chronological list or index of various regulatory disclosures rather than a single, specific report (like a full 10-K, IR, or ER), and it contains numerous notifications related to insider trading (Art. 19 MAR), the most fitting category is 'Directors' Dealing' (DIRS) or a general 'Regulatory Filing' (RNS). However, the sheer volume and explicit referencing of Article 19 (which covers transactions by persons discharging managerial responsibilities and persons closely associated with them) strongly suggest that the primary focus or the most frequent type of disclosure listed here relates to insider transactions. Given the options, 'DIRS' (Director's Dealing) captures a significant and recurring theme (multiple Art. 19 notifications). If the document were purely a list of *all* regulatory events, RNS might be appropriate, but the strong presence of insider trade notifications makes DIRS a strong candidate. Since the document is a summary of various regulatory events, and not just one type, RNS (Regulatory Filings - general/miscellaneous) is often used for such aggregated disclosure lists, but DIRS is highly specific to the most numerous entries (Art. 19). Let's re-evaluate based on the definitions. DIRS is for 'Report of personal share transactions by company directors and executives (insider trades)'. This document lists many such reports. It also lists loan repayments (CAP) and dividend notices (DIV). Because it aggregates multiple distinct regulatory events (insider trades, financing, dividend decisions, and report announcements), the most comprehensive fit for a mixed regulatory bulletin is RNS (Regulatory Filings - general fallback). However, looking closely at the structure, it appears to be a mandatory disclosure page summarizing all inside information released under MAR. The most specific recurring item is the Art. 19 notifications (insider trades). If we must choose the single best fit for the *content* presented, DIRS is heavily represented. But since it also contains financing updates and dividend details, RNS (Regulatory Filings) serves as the best catch-all for this mixed regulatory bulletin. FY 2023
2024-01-29 Bulgarian
SFI Q4_2023_deklaracii po 100o.pdf
Audit Report / Information Classification · 95% confidence The document is a formal declaration ("ДЕКЛАРАЦИЯ") signed by the Executive Member of the Board of Directors and the Chief Accountant of "Sopharma Properties" REIT (АДСИЦ). The declaration explicitly states that the set of financial statements as of 31.12.2023 and the interim activity report as of 31.12.2023 "reflect faithfully and fairly" the company's financial position and performance, referencing specific articles of the Bulgarian Public Offering of Securities Act (ЗППЦК). This structure—a formal statement by management attesting to the accuracy of financial reports for a specific period (31.12.2023, which is year-end)—is characteristic of the required sign-off accompanying annual or interim financial reports. Since the document explicitly mentions and attests to the accuracy of the 'financial statements as of 31.12.2023' and the 'interim activity report' (Междинният доклад за дейността), it is closely tied to the formal reporting process. Given the date 31.12.2023, this is likely related to the Annual Report (10-K equivalent) or the final year-end reporting package. However, the document itself is not the full financial report (10-K) or the comprehensive interim report (IR). It is a mandatory declaration that accompanies these reports. In many regulatory contexts, such mandatory attestations or management certifications are often filed alongside the main reports. Given the options, this declaration serves as a formal governance/reporting component. Since it specifically covers the year-end financial statements (31.12.2023), it is most closely associated with the Annual Report process (10-K). If it were a declaration for a mid-year report, IR would be more appropriate, but the year-end context points towards the annual filing cycle. Considering the definitions, this is a formal declaration related to the annual financial reporting, making it a component of the overall Annual Report filing structure, but since it's a specific declaration, and not the full report, we must choose the best fit. It is not a standard 10-K, ER, or AR. It is a formal declaration of management responsibility over the financial statements. This type of document often falls under general regulatory filings (RNS) or governance (CGR) if a specific code for management certification isn't available. However, because it directly certifies the *financial statements* (which are the core of the 10-K/AR), and given the high confidence required, I will classify it as a component strongly related to the Annual Report filing, but since it's a declaration, and not the report itself, and it's not a proxy statement (DEF 14A) or a general governance report (CGR), the most appropriate category for a mandatory, specific regulatory sign-off that isn't explicitly covered elsewhere is often RNS (Regulatory Filings) or potentially CGR (Governance Information) as it relates to management responsibility. Given the content is purely financial statement certification, and not general governance rules, RNS is the safest fallback for a specific, non-standard declaration. Revisiting the definitions: It is a formal declaration required by law regarding the financial statements. This is a key governance/reporting requirement. It is not a proxy (DEF 14A), nor a general governance report (CGR). It is a specific regulatory filing component. I will classify it as RNS as it is a specific regulatory declaration that doesn't fit the main report types (10-K, IR) or other specific announcements (DIV, DIRS, etc.). FY 2023
2024-01-29 Bulgarian
101_SFI_FS 2023 Q4.pdf
Interim / Quarterly Report Classification · 95% confidence The document contains comprehensive financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, Statement of Cash Flows, and Statement of Changes in Equity for the fiscal year ending December 31, 2023. It provides detailed financial data and analysis for the period, which fits the definition of an Interim or Quarterly Report (IR) as it represents a substantive financial report for a specific period, even though it is labeled as a 'preliminary' report. FY 2023
2024-01-29 Bulgarian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.